COVID-19   

Questions discussed in this category



Would you have a different opinion based on whether it is a new therapy or an existing and previously well-tolerated therapy for the patient?

If so, what patients do you recommend get one and do you have concerns for patients who also may be receiving chemotherapy as the CDC guidelines recom...

Both the patient's nasopharyngeal swab and stem cells themselves resulted COVID positive post-harvesting.

E.g., inflammatory polyarthritis or inflammatory myopathy with onset within 2 weeks of documented COVID infection

I am considering every 6 week pembrolizumab dosing in patients >70 years old in whom I want to reduce clinic visits for, especially in the context ...

I know many centers are exercising extra precautions in light of the new concerns with coronavirus. How are people explaining things to their patients...

For patients with low risk, early stage, hormone receptor positive, HER2 negative breast cancer who initiated endocrine therapy in order to delay thei...

Current guidelines do not support its use, but the EMPACTA trial suggests it may be effective in a subpopulation of patients.

Are you employing more or less primary chemoRT v. surgery for some cancers? Are you dose de-escalating? What are issues radiation oncologists should b...

Would you consider it off-trial during the pandemic? There is some older data for treatment of pneumonia with single-fraction low-dose radiotherapy, w...

Any differences in the risks between SBRT vs. conventionally fractionation? Concurrent immunotherapy? 

How are you changing your parent/visitor policies?  Are you testing for COVID-19 in all febrile patients? Has COVID-19 changed the care settings...

Are you doing more TNT to prolong time to surgery? If so, do are you starting with CRT or chemotherapy?

What if the patient has a history of confirmed COVID-19 but has since recovered?

Our hospital is currently testing (PCR) for COVID-19 in all inpatients and outpatients undergoing surgical/"aerosolizing" procedures. Since radiation ...

Would you consider genomic assays before neoadjuvant chemotherapy? How would you modify your treatment given the COVID-19 pandemic?

Please see this article for referrence https://www.sciencedirect.com/science/article/pii/S0167814020301638

What are the risks of infection with COVID-19 if using immunotherapy?  

For example, would you consider switching to an outpatient regimen in lieu of AIM for metastatic soft tissue sarcoma?

Many hormone positive patients are beginning hormone therapy until they can go to surgery. With a prolonged pause in routine procedures seeming very l...

Should staging and treatment decisions be made based on imaging alone?

Would the recommendation differ based on HR+ vs. TNBC vs HER2+ classification? Would you recommend against immediate breast reconstruction?

Given that majority of benefit is derived from the capecitabine, would this be an acceptable option to decrease patient contact with the healthcare sy...

How would you approach a patient who is receiving chemoRT but has confirmed COVID-19 with minor symptoms, as breaking treatment for 2 weeks quarantine...

Personally, my practice is to guide patients directly to surgery or to do neoadjuvant chemotherapy rather than to do neoadjuvant endocrine therapy, bu...

A case report (https://www.ncbi.nlm.nih.gov/pubmed/32149486) describes severe COVID-19 infection in a pediatric oncology patient. Have you seen simil...

If so, for how long would you expect this increased susceptibility to last? Our medical oncologists often tell patients that their lymphocyte counts m...

Are your practices adjusting priorities at this time? If so, what adjustments are you making? If not, do you have metrics in place that will tell you ...

Should the patient be admitted for observation which will risk exposing other immunocompromised patients to COVID-19, or should the patient be quarant...

When a physical exam is important and telehealth is not a good option, should we be proactive and reschedule or should we continue to see them as sche...

Mitigating the spread of COVID-19 is of utmost priority now that containment measures have failed. Social distancing will help "flatten the curve" of ...

Would you forego neoadjuvant chemotherapy? Are you using growth factor support differently? Any changes to immunotherapy? Other considerations?


Papers discussed in this category


Biotechnol. Prog., 2015 Mar 04

PLoS ONE, 2008 Jul 09

Public Health Rep,

Cochrane Database Syst Rev, 2011 Jul 06

Practical radiation oncology, 2019

BMJ (Clinical research ed.), 2010-03-02

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-01-01

Br. J. Cancer, 2013 Feb 05

Int J Radiat Oncol Biol Phys, 2010 Aug 21

Int. J. Radiat. Oncol. Biol. Phys.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-06-10

Lancet Oncol., 2020 Mar 03

Lancet, 2020 Feb 07

JAMA Netw Open, 2020 Feb 05

Lancet Oncol., 2020 Feb 14

Ann. Oncol., 2020 Mar 26

Hong Kong medical journal = Xianggang yi xue za zhi, 2003-12

Lancet, 2020 Mar 04

Intensive Care Med, 2020 Mar 03

Lancet, 2020 Jan 24

Int J Antimicrob Agents, 2020 Feb 17

Cell Res, 2020 Feb 04

Biosci Trends, 2020 Jan 28

J Natl Cancer Inst, 1991 Mar 20

The New England journal of medicine, 1990-10-04

Pediatrics, 2020 Mar 16

Int. J. Radiat. Oncol. Biol. Phys., 2020 Jan 07

International journal of radiation oncology, biology, physics, 2014-03-15

Int. J. Radiat. Oncol. Biol. Phys., 2019 Feb 16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-08-10

The New England journal of medicine, 2018-07-12

JAMA Oncol, 2019 Sep 30

JAMA,

N Engl J Med, 2020 Mar 27

J. Clin. Oncol., 2019 Jul 24

Radiation oncology (London, England), 2014-01-01

International journal of radiation oncology, biology, physics, 1980-02

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-20

Breast J, 2019 Sep 09

The Lancet. Oncology, 2010-10

Breast Cancer Res. Treat.,

Lancet Oncol., 2013-10-01

Lancet Oncol., 2019 Jan 30

Annals of surgical oncology, 2016-05

Oncology, 2020 Jan 09

The New England journal of medicine, 2018-12-06

Lancet, 2019 Oct 04

British journal of haematology, 2016-06

Hum Exp Toxicol, 2019 May 06

Yale J Biol Med, 2013 Dec 13

Adv Radiat Oncol, 2020 May 05

Cancer Discov, 2020 May 01

Lancet, 2020 May 28

Int. J. Radiat. Oncol. Biol. Phys., 2020 Apr 14

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-06-20

Acta Paediatr., 2020 Mar 23

Pract Radiat Oncol, 2019 Dec 09

Radiother Oncol, 2010 Mar 23

International journal of radiation oncology, biology, physics, 2014-03-15

Ann. Oncol., 2019 Jun 13

The British journal of surgery, 2006-12

Br. J. Haematol., 2020 Apr 30

N Engl J Med, 2020 Apr 29

Rheumatol Int, 2020 Sep 18

N Engl J Med, 2020 Dec 10

N Engl J Med, 2020 Dec 17

Lancet Rheumatol, 2021 Apr 06

N Engl J Med, 2020 Nov 20

Blood,

Lancet Haematol, 2021 Feb 01

Transfusion, 2020 May 27

Vox Sang, 2020 Apr 21

Lancet, 2020 Feb 12

Neurology, 2020 Jul 29

N Engl J Med, 2021 Apr 14

Ann Oncol, 2021 Mar 18

Arthritis Rheumatol, 2021 May 24

N Engl J Med, 2021 Aug 04

Semin Hematol,

Am J Hematol, 2021 Jun 29

Blood, 2010-11-04

Pediatric blood & cancer, 2014-05

British journal of haematology, 2015-05

Oman Med J, 2020 Nov 07

Pediatr Blood Cancer, 2020 Sep 08

Blood Adv,

Hemoglobin, 2021 May 24

BMJ Open, 2019 May 05

Rheumatol Int, 2021 Jan 29

Thromb Res, 2021 Jun 25